News & Views
SeQuant Acquired in Strategic Move
Jun 13 2008
product portfolio.
âWe are pleased to have made this acquisition. It offers Merck superb
opportunities for the future expansion of the chromatography businessâ said Klaus Bischoff, Head of Performance & Life Science Chemicals division at Merck. âBy acquiring SeQuant we are gaining access to a unique technology in the rapidly growing HILIC application segment for analytical and preparative purposes. This technology will enable us to develop and commercialise innovative products that meet the needs of
our customers,â he added. Renamed Merck SeQuant AB, the previous site and all employees of the former company have been retained.
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
Microbiology Society Annual Conference 2024
Apr 08 2024 Edinburgh 2024
Apr 09 2024 Munich, Germany
Apr 10 2024 Helsinki, Finland
Analytica Anacon India & IndiaLabExpo
Apr 15 2024 Mumbai, India
Apr 16 2024 Moscow, Russia